1201675-17-3Relevant academic research and scientific papers
Identification of potent and selective amidobipyridyl inhibitors of protein kinase D
Meredith, Erik L.,Beattie, Kimberly,Burgis, Robin,Capparelli, Michael,Chapo, Joseph,Dipietro, Lucian,Gamber, Gabriel,Enyedy, Istvan,Hood, David B.,Hosagrahara, Vinayak,Jewell, Charles,Koch, Keith A.,Lee, Wendy,Lemon, Douglas D.,Mckinsey, Timothy A.,Miranda, Karl,Pagratis, Nikos,Phan, Dillon,Plato, Craig,Rao, Chang,Rozhitskaya, Olga,Soldermann, Nicolas,Springer, Clayton,Van Eis, Maurice,Vega, Richard B.,Yan, Wanlin,Zhu, Qingming,Monovich, Lauren G.
experimental part, p. 5422 - 5438 (2010/11/18)
The synthesis and biological evaluation of potent and selective PKD inhibitors are described herein. The compounds described in the present study selectively inhibit PKD among other putative HDAC kinases. The PKD inhibitors of the present study blunt phosphorylation and subsequent nuclear export of HDAC4/5 in response to diverse agonists. These compounds further establish the central role of PKD as an HDAC4/5 kinase and enhance the current understanding of cardiac myocyte signal transduction. The in vivo efficacy of a representative example compound on heart morphology is reported herein.
2,4'-BIPYRIDINYL COMPOUNDS AS PROTEIN KINASE D INHIBITORS USEFUL FOR THE TREATMENT OF IA HEART FAILURE AND CANCER
-
Page/Page column 91-92, (2010/01/07)
The present invention provides novel organic compounds of Formula I: methods of use, and pharmaceutical compositions thereof.
